Advance Care Planning in Palliative Care

NCT ID: NCT05662917

Last Updated: 2023-08-08

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 10 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2023-03-10
• Study Completion Date: 2023-12-10

Brief Summary

The question of the end of life is a major public health issue. In the field of palliative care, the notion of anticipation is central for people with a serious and progressive illness. Indeed, an important consideration for general practitioners is the need to anticipate the disease's evolution and the uncomfortable symptoms (physical or psychological) the patient is likely to experience. This approach aims to relieve the patient without delay and thus improve comfort to ensure an acceptable quality of life for patients and their families. Even if the usefulness of anticipatory prescribing seems obvious, their use is not generalized to all palliative care patients. Caregivers are confronted with obstacles to the implementation of these prescriptions, particularly with regard to the relationship with the patient. It can then be assumed that patients' experiences and perceptions may influence symptom management and the use of anticipatory prescriptions. It seems essential to explore this subject. For this purpose, the investigator will carry out a qualitative study based on individual semi-structured interviews with palliative care patients.

Conditions

Palliative Care

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Palliative care patients

• Palliative care patients
• Suffering from a serious and progressive illness (whatever it is)
• Hospitalized in a palliative care unit or followed at home by the hospital's mobile palliative care team

Individual semi-structured interviews

Intervention Type: BEHAVIORAL

After information and written consent, the investigator will interview the participants through a semi-structured individual interview (conducted by an interview guide). The interview is expected to last 45 minutes (variable depending on the subject). It will be recorded by dictaphone, respecting the anonymity of the participant throughout the interview. The subject's participation will end after the interview.

Interventions

Individual semi-structured interviews

After information and written consent, the investigator will interview the participants through a semi-structured individual interview (conducted by an interview guide). The interview is expected to last 45 minutes (variable depending on the subject). It will be recorded by dictaphone, respecting the anonymity of the participant throughout the interview. The subject's participation will end after the interview.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Persons of all genders
• Persons 18 years of age and older
• In a palliative care situation of any serious illness
• Persons hospitalized in palliative care unit at the Givors hospital or followed at home by the Mobile Palliative Care Team
• Patients who have received full information about the study and signed a written consent.

Exclusion Criteria

• Persons under legal protection
• Persons unable to express their consent, making it impossible to conduct interviews: dysarthria, cognitive disorders, mental confusion, altered state of consciousness
• Pregnant or breastfeeding persons

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hospices Civils de Lyon

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Manon JULLIAN

Role: PRINCIPAL_INVESTIGATOR

Multidisciplinary medicine and palliative care department

Locations

Givors Hospital Center - Multidisciplinary medicine and palliative care department

Givors, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Manon JULLIAN

Role: CONTACT

manonjullian@hotmail.fr

4 78 07 30 91 ext. +33

Julien TRAUTMANN, MD

Role: CONTACT

jtrautmann@ch-givors.fr

4 78 07 31 38 ext. +33

Facility Contacts

Manon JULLIAN

Role: primary

mjullian@ch-givors.fr

4 78 07 30 91 ext. +33

Julien TRAUTMANN, MD

Role: backup

jtrautmann@ch-givors.fr

4 78 07 31 38 ext. +33

Other Identifiers

ID-RCB

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL22_0747

Identifier Type: -

Identifier Source: org_study_id